Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

IHE vs IXJ overlap: 34% of top holdings shared

Bottom line

How much do IHE and IXJ overlap?

34% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 57.6% of IHE's assets and 25.4% of IXJ's. They share a meaningful core but differ in the rest of the portfolio.

IXJ holds far more positions (124 vs 59), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

IHEIXJ
Weight overlap (top 25)34%
Shared holdings5
Weight in shared holdings57.6%25.4%
Total positions59124
Expense ratio0.37%0.38%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings IHE and IXJ have in common

Holding% of IHE% of IXJOverlap
Johnson & Johnson22.44%7.04%7.04%
Eli Lilly And Company22.25%10.93%10.93%
Merck & Co., Inc.4.55%4.12%4.12%
Bristol-myers Squibb Company4.37%1.53%1.53%
Pfizer Inc.3.96%1.78%1.78%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in IHE

  1. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
  2. Royalty Pharma Plc — 4.34%
  3. Viatris Inc. — 4.22%
  4. Zoetis Inc. — 3.73%
  5. Jazz Pharmaceuticals Public Limited Company — 3.45%
  6. Elanco Animal Health Incorporated — 2.81%
  7. Axsome Therapeutics, Inc. — 2.42%
  8. Corcept Therapeutics Incorporated — 1.90%
  9. Ligand Pharmaceuticals Incorporated — 1.45%
  10. Definium Therapeutics Inc — 1.39%
  11. Liquidia Corp — 1.28%
  12. Indivior Pharmaceuticals, Inc. — 1.14%
  13. Crinetics Pharmaceuticals Inc — 0.90%
  14. Organon & Co. — 0.81%
  15. Edgewise Therapeutics Inc — 0.70%

Only in IXJ

  1. Abbvie Inc. — 5.12%
  2. Unitedhealth Group Incorporated — 4.40%
  3. Astrazeneca Plc — 3.76%
  4. Roche Holding AG — 3.75%
  5. Novartis AG — 3.71%
  6. Amgen Inc. — 2.54%
  7. Thermo Fisher Scientific Incorporated — 2.42%
  8. Abbott Laboratories — 2.05%
  9. Gilead Sciences, Inc. — 2.04%
  10. Novo Nordisk A/s — 1.99%
  11. Intuitive Surgical, Inc. — 1.83%
  12. Cvs Health Corporation — 1.71%
  13. Vertex Pharmaceuticals Incorporated — 1.64%
  14. Danaher Corporation — 1.56%
  15. Stryker Corporation — 1.41%

Asset mix

Asset typeIHEIXJ
Stocks99.9%99.6%
Cash & short-term funds6.3%1.3%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryIHEIXJ
US96.4%70.6%
CH—10.4%
GB4.3%5.8%
IE3.8%1.6%
JP—3.7%
DK—2.3%
FR—2.0%
DE—1.6%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do IHE and IXJ overlap?
About 34% by weight. 5 securities appear in both funds' top 25 holdings; they make up 57.6% of IHE's assets and 25.4% of IXJ's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do IHE and IXJ have in common?
The largest shared holdings are Eli Lilly And Company, Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Bristol-myers Squibb Company.
Should I own both IHE and IXJ?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, IHE or IXJ?
IXJ is broader, with 124 positions versus 59 for IHE. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.